Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1962 1
1967 1
1975 1
1977 2
1978 1
1979 1
1980 1
1981 1
1982 2
1983 6
1984 1
1985 1
1986 5
1987 6
1988 8
1989 11
1990 11
1991 21
1992 20
1993 21
1994 20
1995 31
1996 41
1997 38
1998 60
1999 77
2000 107
2001 104
2002 108
2003 129
2004 163
2005 188
2006 226
2007 284
2008 325
2009 366
2010 428
2011 496
2012 563
2013 586
2014 636
2015 702
2016 638
2017 717
2018 706
2019 719
2020 785
2021 838
2022 745
2023 761
2024 735
2025 769
2026 398

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12,103 results

Results by year

Filters applied: . Clear all
Page 1
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer.
Powles T, Kann AG, Castellano D, Gross-Goupil M, Nishiyama H, Bracarda S, Bjerggaard Jensen J, Makaroff L, Jiang S, Ku JH, Park SH, Reig Torras O, Ye D, Maruzzo M, Necchi A, Morales-Barrera R, Giunta EF, Lee JL, Tortora G, Ürün Y, Dolowy L, Erdem D, Pinto A, Grando F, Zou W, Assaf ZJ, Vuky J, Degaonkar V, Steinberg EE, Bellmunt J, Gschwend JE; IMvigor011 Investigators. Powles T, et al. Among authors: park sh. N Engl J Med. 2025 Dec 18;393(24):2395-2408. doi: 10.1056/NEJMoa2511885. Epub 2025 Oct 20. N Engl J Med. 2025. PMID: 41124204 Clinical Trial.
Enfortumab vedotin plus pembrolizumab in untreated locally advanced or metastatic urothelial carcinoma: 2.5-year median follow-up of the phase III EV-302/KEYNOTE-A39 trial.
Powles TB, Van der Heijden MS, Loriot Y, Bedke J, Valderrama BP, Iyer G, Kikuchi E, Hoffman-Censits J, Vulsteke C, Drakaki A, Rausch S, Arafat W, Park SH, Swami U, Li JR, Duran I, Gorla S, Homet Moreno B, Yu X, Lu YT, Gupta S. Powles TB, et al. Among authors: park sh. Ann Oncol. 2025 Oct;36(10):1212-1219. doi: 10.1016/j.annonc.2025.05.536. Epub 2025 Jun 1. Ann Oncol. 2025. PMID: 40460988 Free article. Clinical Trial.
Sacituzumab govitecan in advanced urothelial carcinoma: TROPiCS-04, a phase III randomized trial.
Powles T, Tagawa S, Vulsteke C, Gross-Goupil M, Park SH, Necchi A, De Santis M, Duran I, Morales-Barrera R, Guo J, Sternberg CN, Bellmunt J, Goebell PJ, Kovalenko M, Boateng F, Sierecki M, Wang L, Sima CS, Waldes J, Loriot Y, Grivas P. Powles T, et al. Among authors: park sh. Ann Oncol. 2025 May;36(5):561-571. doi: 10.1016/j.annonc.2025.01.011. Epub 2025 Feb 11. Ann Oncol. 2025. PMID: 39934055 Free article. Clinical Trial.
Cross-organ metabolite production and consumption in healthy and atherogenic conditions.
Bae H, Jung S, Le J, Tamburini I, Kim J, Wang E, Song WS, Choi W, Jang KH, Kang T, Lopez ML, Ramirez C, Mohanty I, Kelly ME, Kim J, Kim R, Park SH, Baek J, Mendez B, Petrus P, de Aguiar Vallim TQ, Nicholas DA, Smith Q, Lee G, Seldin M, Jang C. Bae H, et al. Among authors: park sh. Cell. 2025 Aug 7;188(16):4441-4455.e16. doi: 10.1016/j.cell.2025.05.001. Epub 2025 May 27. Cell. 2025. PMID: 40436017 Free PMC article.
Dietary fibre-adapted gut microbiome clears dietary fructose and reverses hepatic steatosis.
Jung S, Bae H, Song WS, Chun Y, Le J, Alam Y, Verlande A, Chun SK, Kim J, Kelly ME, Lopez ML, Park SH, Onofre D, Baek J, Jang KH, Rubtsova VI, Anica A, Masri S, Lee G, Jang C. Jung S, et al. Among authors: park sh. Nat Metab. 2025 Sep;7(9):1801-1818. doi: 10.1038/s42255-025-01356-0. Epub 2025 Sep 15. Nat Metab. 2025. PMID: 40954286 Free PMC article.
Nicotinic acid riboside maintains NAD+ homeostasis and ameliorates aging-associated NAD+ decline.
Song WS, Shen X, Du K, Ramirez CB, Park SH, Cao Y, Le J, Bae H, Kim J, Chun Y, Khong NJ, Kim M, Jung S, Choi W, Lopez ML, Said Z, Song Z, Lee SG, Nicholas D, Sasaki Y, Milbrandt J, Imagawa DK, Skowronska-Krawczyk D, Chen D, Lee G, Jang C, Yang Q. Song WS, et al. Among authors: park sh. Cell Metab. 2025 Jul 1;37(7):1499-1514.e4. doi: 10.1016/j.cmet.2025.04.007. Epub 2025 May 1. Cell Metab. 2025. PMID: 40315855 Free PMC article.
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274.
Galsky MD, Gschwend JE, Milowsky MI, Schenker M, Valderrama BP, Tomita Y, Bamias A, Lebret T, Shariat SF, Park SH, Agerbaek M, Jha G, Stenner F, Ye D, Giudici F, Connors J, Gupta S, Chhibber A, Zhang J, Bajorin DF, Witjes JA. Galsky MD, et al. Among authors: park sh. Ann Oncol. 2026 Jan;37(1):69-78. doi: 10.1016/j.annonc.2025.09.139. Epub 2025 Oct 17. Ann Oncol. 2026. PMID: 41110694 Free article. Clinical Trial.
NKG2D-mediated cytotoxicity of CD4 cytotoxic T cells in multiple myeloma.
Kim S, Kwak JE, Koh JY, Lee JE, Kook HW, Kim M, Chung H, Kim YR, Kim SJ, Kim JS, Cheong JW, Lee MG, Lee H, Park SH, Shin EC, Shin S, Yoon SO, Choi IK, Lee JS, Cho H. Kim S, et al. Among authors: park sh. Blood. 2025 Jul 24;146(4):456-470. doi: 10.1182/blood.2024025875. Blood. 2025. PMID: 40106762
12,103 results
You have reached the last available page of results. Please see the User Guide for more information.